Victory Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,075	Closed	-$19K	–	2760
2022 Q3	$19K	Sell	16,075 -2,925	-15%	-$4.56K	﹤0.01%	2634
2022 Q2	$34K	Buy	19,000 +88	+0.5%	+$130	﹤0.01%	2583
2022 Q1	$38K	Buy	18,912 +1,138	+6%	+$2.23K	﹤0.01%	2614
2021 Q4	$48K	Buy	17,774 +1,078	+6%	+$3.98K	﹤0.01%	2644
2021 Q3	$74K	Buy	16,696 +1,372	+9%	+$6.61K	﹤0.01%	2655
2021 Q2	$89K	Sell	15,324 -640	-4%	-$3.75K	﹤0.01%	2612
2021 Q1	$112K	Buy	15,964 +2,056	+15%	+$13.8K	﹤0.01%	2590
2020 Q4	$67K	Buy	13,908 +728	+6%	+$3.68K	﹤0.01%	2442
2020 Q3	$77K	Buy	13,180 +161	+1%	+$963	﹤0.01%	2360
2020 Q2	$88K	Sell	13,019 -8,865	-41%	-$67.1K	﹤0.01%	2367
2020 Q1	$140K	Buy	+21,884	New	+$176K	﹤0.01%	2432
2019 Q4	–	Sell	-8,876	Closed	-$35K	–	3514
2019 Q3	$35K	Buy	+8,876	New	+$71.8K	﹤0.01%	2844
2018 Q3	–	Sell	-189	Closed	-$9K	–	1916
2018 Q2	$9K	Sell	189 -14,440	-99%	-$702K	﹤0.01%	1812
2018 Q1	$772K	Buy	14,629 +14,440	+7,640%	+$843K	﹤0.01%	1289
2017 Q4	$13K	Hold	189	–	–	﹤0.01%	1800
2017 Q3	$16K	Hold	189	–	–	﹤0.01%	1789
2017 Q2	$18K	Sell	189 -21,204	-99%	-$1.3M	﹤0.01%	1775
2017 Q1	$1.36M	Buy	21,393 +21,208	+11,464%	+$1.29M	﹤0.01%	1050
2016 Q4	$8K	Buy	185 +11	+6%	+$387	﹤0.01%	1782
2016 Q3	$6K	Buy	174 +13	+8%	+$279	﹤0.01%	1771
2016 Q2	$2K	Buy	161 +4	+3%	+$58	﹤0.01%	1632
2016 Q1	$3K	Buy	157 +13	+9%	+$275	﹤0.01%	1658
2015 Q4	$5K	Buy	144 +10	+7%	+$645	﹤0.01%	1674
2015 Q3	$12K	Buy	134 +13	+11%	+$1.13K	﹤0.01%	1603
2015 Q2	$11K	Buy	+121	New	+$10.4K	﹤0.01%	1618